Genmab A/S
CSE:GMAB
Genmab A/S
CSE:GMAB
Price:
1 399.5
DKK
-1.03%
Market Closed
Market Cap:
92.6B
DKK
Income Statement
Earnings Waterfall
Genmab A/S
Genmab A/S
|
Revenue
|
21.5B
DKK
|
|
Cost of Revenue
|
-985m
DKK
|
|
Gross Profit
|
20.5B
DKK
|
|
Operating Expenses
|
-13.5B
DKK
|
|
Operating Income
|
7.1B
DKK
|
|
Other Expenses
|
765m
DKK
|
|
Net Income
|
7.8B
DKK
|
Income Statement
Genmab A/S
Genmab A/S
Currency: DKK
Millions
TTM
| Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
850
N/A
|
710
-16%
|
768
+8%
|
774
+1%
|
1 133
+46%
|
1 197
+6%
|
1 377
+15%
|
1 463
+6%
|
1 816
+24%
|
1 897
+4%
|
2 316
+22%
|
2 275
-2%
|
2 365
+4%
|
2 796
+18%
|
2 532
-9%
|
2 807
+11%
|
3 025
+8%
|
2 935
-3%
|
3 199
+9%
|
3 641
+14%
|
5 366
+47%
|
5 667
+6%
|
10 344
+83%
|
11 028
+7%
|
10 111
-8%
|
10 800
+7%
|
7 321
-32%
|
7 907
+8%
|
8 417
+6%
|
9 020
+7%
|
10 210
+13%
|
11 987
+17%
|
14 505
+21%
|
15 330
+6%
|
16 366
+7%
|
17 023
+4%
|
16 474
-3%
|
17 763
+8%
|
18 967
+7%
|
19 763
+4%
|
21 526
+9%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(100)
|
(226)
|
(411)
|
(601)
|
(774)
|
(985)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
8 417
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
14 505
N/A
|
0
N/A
|
0
N/A
|
4 644
N/A
|
16 248
+250%
|
13 154
-19%
|
18 366
+40%
|
18 989
+3%
|
20 541
+8%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(585)
|
(368)
|
(355)
|
(358)
|
(403)
|
(623)
|
(700)
|
(743)
|
(763)
|
(814)
|
(839)
|
(926)
|
(999)
|
(1 174)
|
(1 311)
|
(1 445)
|
(1 645)
|
(1 905)
|
(2 167)
|
(2 458)
|
(2 728)
|
(2 932)
|
(3 249)
|
(3 426)
|
(3 798)
|
(4 026)
|
(4 257)
|
(4 811)
|
(5 464)
|
(6 020)
|
(6 750)
|
(7 486)
|
(8 200)
|
(9 050)
|
(9 836)
|
(10 607)
|
(10 927)
|
(11 667)
|
(12 362)
|
(12 583)
|
(13 462)
|
|
| Selling, General & Administrative |
(80)
|
(86)
|
(90)
|
(92)
|
(91)
|
(93)
|
(94)
|
(101)
|
(102)
|
(110)
|
(121)
|
(131)
|
(147)
|
(157)
|
(177)
|
(195)
|
(212)
|
(240)
|
(258)
|
(284)
|
(339)
|
(377)
|
(483)
|
(547)
|
(651)
|
(756)
|
(841)
|
(1 002)
|
(1 266)
|
(1 534)
|
(1 903)
|
(2 267)
|
(2 638)
|
(2 900)
|
(3 115)
|
(3 284)
|
(3 252)
|
(3 478)
|
(3 524)
|
(3 550)
|
(3 754)
|
|
| Research & Development |
(506)
|
(459)
|
(441)
|
(443)
|
(461)
|
(529)
|
(606)
|
(642)
|
(620)
|
(704)
|
(718)
|
(795)
|
(805)
|
(1 017)
|
(1 134)
|
(1 250)
|
(1 345)
|
(1 665)
|
(1 909)
|
(2 174)
|
(2 250)
|
(2 555)
|
(2 767)
|
(2 880)
|
(2 937)
|
0
|
(1 642)
|
(2 035)
|
(4 181)
|
(4 486)
|
(4 847)
|
(5 219)
|
(5 454)
|
(6 150)
|
(6 721)
|
(7 323)
|
(7 575)
|
(8 189)
|
(8 838)
|
(9 033)
|
(9 594)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
(27)
|
0
|
0
|
0
|
(41)
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
(88)
|
0
|
0
|
0
|
(139)
|
0
|
0
|
0
|
(210)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(108)
|
0
|
0
|
0
|
(100)
|
0
|
0
|
0
|
(114)
|
|
| Other Operating Expenses |
0
|
176
|
176
|
176
|
176
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3 270)
|
(1 774)
|
(1 774)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
265
N/A
|
342
+29%
|
413
+21%
|
416
+1%
|
730
+75%
|
574
-21%
|
676
+18%
|
720
+7%
|
1 053
+46%
|
1 083
+3%
|
1 477
+36%
|
1 349
-9%
|
1 366
+1%
|
1 622
+19%
|
1 221
-25%
|
1 363
+12%
|
1 380
+1%
|
1 030
-25%
|
1 032
+0%
|
1 183
+15%
|
2 638
+123%
|
2 735
+4%
|
7 095
+159%
|
7 602
+7%
|
6 313
-17%
|
6 774
+7%
|
3 064
-55%
|
3 096
+1%
|
2 953
-5%
|
3 000
+2%
|
3 460
+15%
|
4 501
+30%
|
6 305
+40%
|
6 280
0%
|
6 530
+4%
|
6 316
-3%
|
5 321
-16%
|
5 685
+7%
|
6 004
+6%
|
6 406
+7%
|
7 079
+11%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
32
|
73
|
45
|
22
|
27
|
(45)
|
4
|
9
|
77
|
80
|
(92)
|
(160)
|
(280)
|
(323)
|
22
|
118
|
232
|
420
|
193
|
511
|
221
|
384
|
242
|
(294)
|
(409)
|
200
|
4
|
472
|
965
|
171
|
1 778
|
2 838
|
678
|
429
|
(587)
|
(943)
|
316
|
1 382
|
1 643
|
275
|
2 461
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(38)
|
0
|
0
|
0
|
0
|
0
|
(176)
|
(193)
|
(376)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
297
N/A
|
415
+40%
|
458
+10%
|
438
-4%
|
758
+73%
|
529
-30%
|
681
+29%
|
729
+7%
|
1 130
+55%
|
1 162
+3%
|
1 385
+19%
|
1 189
-14%
|
1 064
-11%
|
1 299
+22%
|
1 243
-4%
|
1 481
+19%
|
1 612
+9%
|
1 450
-10%
|
1 226
-15%
|
1 694
+38%
|
2 859
+69%
|
3 119
+9%
|
7 336
+135%
|
7 308
0%
|
5 904
-19%
|
6 974
+18%
|
3 068
-56%
|
3 568
+16%
|
3 918
+10%
|
3 171
-19%
|
5 238
+65%
|
7 339
+40%
|
6 945
-5%
|
6 709
-3%
|
5 943
-11%
|
5 373
-10%
|
5 637
+5%
|
7 067
+25%
|
7 471
+6%
|
6 488
-13%
|
9 164
+41%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
4
|
5
|
5
|
5
|
6
|
6
|
6
|
6
|
57
|
53
|
(31)
|
(30)
|
40
|
(13)
|
(4)
|
(57)
|
(140)
|
(105)
|
(56)
|
(166)
|
(693)
|
(756)
|
(1 681)
|
(1 659)
|
(1 146)
|
(1 389)
|
(555)
|
(695)
|
(961)
|
(794)
|
(1 276)
|
(1 685)
|
(1 493)
|
(1 426)
|
(1 194)
|
(1 077)
|
(1 285)
|
(1 616)
|
(1 969)
|
(1 849)
|
(1 320)
|
|
| Income from Continuing Operations |
301
|
420
|
463
|
443
|
764
|
535
|
687
|
735
|
1 187
|
1 215
|
1 354
|
1 159
|
1 104
|
1 286
|
1 239
|
1 424
|
1 472
|
1 346
|
1 170
|
1 528
|
2 166
|
2 363
|
5 656
|
5 649
|
4 758
|
5 585
|
2 513
|
2 873
|
2 957
|
2 377
|
3 962
|
5 654
|
5 452
|
5 283
|
4 749
|
4 296
|
4 352
|
5 451
|
5 502
|
4 639
|
7 844
|
|
| Net Income (Common) |
301
N/A
|
420
+39%
|
463
+10%
|
443
-4%
|
764
+72%
|
535
-30%
|
687
+28%
|
735
+7%
|
1 187
+61%
|
1 215
+2%
|
1 354
+11%
|
1 159
-14%
|
1 104
-5%
|
1 286
+17%
|
1 239
-4%
|
1 424
+15%
|
1 472
+3%
|
1 346
-9%
|
1 170
-13%
|
1 528
+31%
|
2 166
+42%
|
2 363
+9%
|
5 656
+139%
|
5 649
0%
|
4 758
-16%
|
5 585
+17%
|
2 513
-55%
|
2 873
+14%
|
2 957
+3%
|
2 377
-20%
|
3 962
+67%
|
5 654
+43%
|
5 452
-4%
|
5 283
-3%
|
4 749
-10%
|
4 296
-10%
|
4 352
+1%
|
5 451
+25%
|
5 502
+1%
|
4 639
-16%
|
7 844
+69%
|
|
| EPS (Diluted) |
5.29
N/A
|
7.03
+33%
|
7.57
+8%
|
7.26
-4%
|
13.05
+80%
|
8.95
-31%
|
11.1
+24%
|
11.89
+7%
|
19.22
+62%
|
20.01
+4%
|
21.8
+9%
|
18.36
-16%
|
17.77
-3%
|
20.71
+17%
|
20.02
-3%
|
22.97
+15%
|
23.73
+3%
|
21.8
-8%
|
18.6
-15%
|
23.55
+27%
|
34.04
+45%
|
35.92
+6%
|
85.97
+139%
|
85.69
0%
|
72.22
-16%
|
84.64
+17%
|
38.1
-55%
|
43.48
+14%
|
44.77
+3%
|
36.03
-20%
|
60.04
+67%
|
85.77
+43%
|
82.59
-4%
|
80.18
-3%
|
72.12
-10%
|
65.2
-10%
|
66.02
+1%
|
83.01
+26%
|
84.79
+2%
|
72.58
-14%
|
121.36
+67%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
